[email protected]

Floating, Production, Storage, and Offloading Vessels (FPSOs) are gaining significant importance in the offshore oil and gas industry, as they could be set up at offshore sites with simpler procedures, and eliminate the need for using complex pipeline network to transport oil or gas from the offshore production site. This makes FPSOs deployable in deepwater offshore oil fields, where subsea...

Upstream process is vital in the manufacturing of biopharmaceuticals to have control over growth conditions and nutrients which eventually reflects in an increased overall yield. GBI Research analysis shows that the total upstream market was calculated at $5.4 billion in 2009. The market is expected to grow at a CAGR of 11% for the period 2009-2016, and is expected to reach $11.7 billion by 2016...

GlobalData estimated the dementia therapeutics market in 2010 to be worth $6.6 billion and forecasts it to grow at 10.5% annually for the next seven years to reach $13.4 billion by 2017. This significant growth is primarily attributed to increasing therapeutic options for the treatment of dementia. In addition, the successful launch of some of the molecular targeted therapies, such as...

The wind energy market has witnessed enormous growth in the past; the world’s cumulative installed capacity reached 160,014 Megawatts (MW) in 2009, from 24,052 MW in 2001, at a Compound Annual Growth Rate of 27%. The exponential growth of the wind energy market is fueled by the depleting reserves of fossil fuels, declining cost of wind power generation and a growing sensitivity for the...

GlobalData estimates that the global acute pain therapeutics market was valued at $10.3 billion in 2010, and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 4.7% over the next seven years, to reach $14.2 billion by 2017. This slow growth is primarily attributed to a low treatment seeking behavior, disease awareness and usage of generic drugs. The current competitive landscape...

GlobalData estimated the global liver cirrhosis market to be valued at $1.56 billion in 2010. It is expected to grow to $2.03 billion with a Compound Annual Growth Rate (CAGR) of 3.8% by 2017. This growth is primarily attributed to the increasing prevalence of the disease due to increase in alcoholic liver disease, nonalcoholic steatohepatitis (NASH) and the large group of patients who were...